The evaluation of the HIV/AIDS Drug Access Initiatives in Côte D'Ivoire, Senegal and Uganda
Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire
Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy
Prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients who have rebound in viral load while receiving antiretroviral therapy in the UNAIDS–Drug Access Initiative in Abidjan, Côte d'Ivoire
Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy
Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV drug access initiative – Uganda
Antiretroviral therapy in HIV-2-infected patients
Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients
Socio-economic and health characteristics of HIV-infected patients seeking care in relation to access to the Drug Access Initiative and to antiretroviral treatment in Côte d'Ivoire
Access to antiretroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Côte d'Ivoire
Physicians' knowledge and attitudes toward HIV care in the context of the UNAIDS/Ministry of Health Drug Access Initiative in Côte d'Ivoire
The most efficient use of resources to identify those in need of antiretroviral treatment in Africa
Access to antiretroviral drugs and AIDS management in Senegal
Adherence to HAART and its principal determinants in a cohort of Senegalese adults
Antiretroviral use in Ouagadougou, Burkina Faso